Squarepoint Ops LLC Pfizer Inc Call Options Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $6.7 Million - $7.59 Million	241,900 Added 64.64%	616,100 $17.8 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $23.2 Million - $27.2 Million	-917,900 Reduced 71.04%	374,200 $10.5 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $24.5 Million - $28.1 Million	945,700 Added 273.01%	1,292,100 $35.9 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $9.84 Million - $12.8 Million	-376,400 Reduced 52.08%	346,400 $9.97 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $9.04 Million - $10.5 Million	250,200 Added 52.94%	722,800 $26.5 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $8.66 Million - $11.3 Million	-219,900 Reduced 31.75%	472,600 $19.3 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $438,375 - $572,250	10,500 Added 1.54%	692,500 $35.5 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $3.91 Million - $4.78 Million	-89,400 Reduced 11.59%	682,000 $29.8 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1.6 Million - $1.89 Million	34,300 Added 4.65%	771,400 $40.4 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $7.94 Million - $9.84 Million	173,500 Added 30.78%	737,100 $38.2 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $814,004 - $1.21 Million	-19,700 Reduced 3.38%	563,600 $33.3 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $2.06 Million - $2.64 Million	-52,400 Reduced 8.24%	583,300 $25.1 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $16.5 Million - $18.7 Million	459,700 Added 261.19%	635,700 $24.9 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $5.71 Million - $6.44 Million	170,400 Added 3042.86%	176,000 $6.38 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $90,369 - $114,912	-2,700 Reduced 32.53%	5,600 $206,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $96,384 - $116,928	-3,200 Reduced 27.83%	8,300 $271,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $217,272 - $246,576	-6,600 Reduced 36.46%	11,500 $451,000
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $152,703 - $198,011	4,700 Added 35.07%	18,100 $650,000
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $22,187 - $24,912	600 Added 4.69%	13,400 $580,000
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $480,000 - $527,360	12,800 New	12,800 $544,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.2 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$10.9 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.45 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.2 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.34 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account